This innovative solution leverages biosynthetic gene cluster mining and metabolomics to identify and engineer microbial strains for large-scale sustainable production of bioactive molecules. It aims to enhance natural product discovery and optimize strain performance.
This solution focuses on the sustainable production of bioactive molecules by engineering microbial strains. By utilizing advanced techniques such as biosynthetic gene cluster (BGC) mining and metabolomics, the technology identifies and characterizes target bioactive molecules. The ultimate goal is to engineer microbial strains to produce these molecules at scale, facilitating the discovery of new natural products and enhancing their production efficiency.
This technology is at TRL 4, indicating it has been validated in a laboratory environment with a clear development pathway towards commercial application.